Sparsh Superspeciality Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 1.00 M
as on 09-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.61 Cr
as on 09-07-2024
- Revenue -22.82%
(FY 2023)
- Profit -115.53%
(FY 2023)
- Ebitda -47.20%
(FY 2023)
- Net Worth -5.88%
(FY 2023)
- Total Assets 181.39%
(FY 2023)
About Sparsh Superspeciality Hospital And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.61 Cr.
Rohit Nalawade, Sachin Nalavade, and Rakesh Singh serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC284036
- Company No.
284036
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Panvel, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sparsh Superspeciality Hospital And Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Nalawade  | Director | 25-Jul-2016 | Current |
| Sachin Nalavade | Director | 25-Jul-2016 | Current |
| Rakesh Singh | Director | 25-Jul-2016 | Current |
Financial Performance of Sparsh Superspeciality Hospital And Research Centre.
Sparsh Superspeciality Hospital And Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.82% decrease. The company also saw a substantial fall in profitability, with a 115.53% decrease in profit. The company's net worth dipped by a decrease of 5.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sparsh Superspeciality Hospital And Research Centre?
In 2023, Sparsh Superspeciality Hospital And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Mar 2023 | ₹7.29 Cr | Open |
Others Creation Date: 29 Jun 2017 | ₹1.21 M | Open |
Others Creation Date: 30 Mar 2017 | ₹1.09 M | Open |
How Many Employees Work at Sparsh Superspeciality Hospital And Research Centre?
Unlock and access historical data on people associated with Sparsh Superspeciality Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sparsh Superspeciality Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparsh Superspeciality Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
